Alerus Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$1.51M Buy
29,932
+331
+1% +$16.2K 0.26% 86
2015
Q4
$1.49M Buy
29,601
+8,260
+39% +$416K 0.25% 85
2015
Q3
$1M Buy
21,341
+2,592
+14% +$138K 0.18% 90
2015
Q2
$1.03M Hold
18,749
0.17% 87
2015
Q1
$1.03M Buy
18,749
+4,096
+28% +$232K 0.17% 88
2014
Q4
$794K Buy
14,653
+140
+1% +$7.8K 0.13% 89
2014
Q3
$821K Sell
14,513
-2,398
-14% -$135K 0.14% 86
2014
Q2
$933K Buy
16,911
+458
+3% +$25K 0.16% 83
2014
Q1
$891K Buy
16,453
+628
+4% +$32.5K 0.19% 83
2013
Q4
$757K Buy
15,825
+1,850
+13% +$84.6K 0.17% 94
2013
Q3
$635K Buy
13,975
+881
+7% +$40.2K 0.13% 95
2013
Q2
$581K Buy
+13,094
New +$585K 0.09% 103

Other funds holding MRK

Alerus Investment Advisors's MRK Position: Q1 2016 in Review

Alerus Investment Advisors increased its Merck (MRK) stake by 1.1% in Q1 2016, buying an estimated $16.2K and bringing the position to 29,932 shares worth $1.51M. The position accounts for 0.26% of the portfolio, ranked #86.

Alerus Investment Advisors first reported a position in MRK in Q2 2013 and has held it in 12 quarters since. 1,745 funds tracked by Wall St. Rank hold MRK as of Q1 2016.

  • Alerus Investment Advisors held 29,932 shares of Merck worth $1.51M as of Q1 2016.
  • Alerus Investment Advisors bought 331 Merck shares in Q1 2016, an estimated $16.2K.
  • Merck made up 0.26% of Alerus Investment Advisors's portfolio in Q1 2016, its #86 holding.
  • Alerus Investment Advisors first reported a position in Merck in Q2 2013 and has held it in 12 quarters since.
  • 1,745 funds tracked by Wall St. Rank held Merck as of Q1 2016.

Based on Alerus Investment Advisors's 13F filing for Q1 2016, filed 4 May 2016.